New Novartis data in relapsing MS reinforce benefits of Kesimpta for first-line and switch patients: Basel Friday, September 20, 2024, 12:00 Hrs [IST] Novartis announced new data ...
July 24, 2024 — Scientists have discovered that the serrated edges of Komodo dragons' teeth are tipped with iron. The study gives new insight into how Komodo dragons keep their teeth razor-sharp ...
Der Schweizer Aktienmarkt hat am Mittwoch im Vorfeld des mit Spannung erwarteten Zinsentscheids in den USA nachgegeben. Nach ...
Novartis' new data for Kesimpta showed reduced disability progression in relapsing multiple sclerosis patients. Continuous ...
Die US-Gesundheitsbehörde FDA hat das Novartis-Medikament Kisqali für die Behandlung von Patientinnen mit einer bestimmten ...
BASF plant Umbau-Pläne für Agrarchemie und Beschichtungen.Google siegt vor EU-Gericht.Tupperware stellt US-Insolvenzantrag.
Novartis hat neue Daten zu seinem Medikament Kesimpta vorgelegt, das zur Behandlung von schubförmiger Multipler Sklerose (RMS ...
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
When Roche's Genentech gained approval for Ocrevus in 2017, the first-in- | On the same day that Roche gained an FDA approval ...
Patients will be able to get a 10 minute injection of the Roche drug, instead of an hours-long infusion. Novartis already has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback